Undp Office IN Turkmenistan Pharmaceutical Import Profile — Turkmenistan (DGFT 2022–2026)

Name: Undp Office IN Turkmenistan Pharmaceutical Import Records from India — 2 Products, $800.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Undp Office IN Turkmenistan — Pharmaceutical Importer Profile (2026) | 2 Products, $800.0K Trade | TransData Nexus

Undp Office IN Turkmenistan

Pharmaceutical Importer · Turkmenistan · Antiviral & HIV Medications Focus · $800.0K Total Trade · DGFT Verified

Undp Office IN Turkmenistan is a pharmaceutical importer based in Turkmenistan with a total trade value of $800.0K across 2 products in 1 therapeutic categories. Based on 16 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Undp Office IN Turkmenistan sources from 5 verified Indian suppliers, with Mylan Laboratories Limited accounting for 53.8% of imports.

Undp Office IN Turkmenistan — Import Portfolio & Supplier Network

Undp Office IN Turkmenistan import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Undp Office IN Turkmenistan?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Mylan Laboratories Limited	$448.8K	14	53.8%
Rr Pharmaceuticals Private Limited	$150.0K	3	18.0%
Lupin Limited	$132.2K

What Formulations Does Undp Office IN Turkmenistan Import?

Formulation	Value	Ships
Carbo spal 450 (carboplatin 450MG concentrate for SOL.for infusion 10MG/ml45ml)(b.no.23kcb01,2,3 m:11/23,e:10/25	$150.0K	3
Sofosbuvir velpatasvir tablets 400MG 100MG hdpe bottle of 28 tablets packs	$103.9K	3
Sofosbuvir/velpatasvir,tablets	$100.0K	2
4 fdc USP tablet undp(eng/sp/por/fr	$100.0K	2
Sofosbuvir 400MG+daclatasvir 60MG tablets 28's packs	$89.0K	3
Desmopressin acetate nasal solution 0 01 nasal spray 5ML vial Each ML containsdesmopressin acetate 0 1MG qty	$50.0K	1
Sofosbuvir 400MG daclatasvir 60MG tablets 28 s 5100 packs x 28	$50.0K	1
Sofosbuvir/velpatasvir, tablets, 400MG/100MG, (hdpe bottle of 28 tablets) (1800packs x28 nos)	$50.0K	1
Doxorubicin hcl liposome injection, 2MG/ML, 25ML vial Each vial contains doxorubicin hydrochloride 50MG	$50.0K	1
Zoledronic INJ 0.8MG/ML 5ML 1s mylan us(7608975) tax val	$33.3K	1
Isoniazid 100MG tablets (100's) (18504 packs x100 nos	$22.5K	3
Pharma : isoniazid tablets 100MG row	$21.5K	2
Ethambutol 400 24x28t ethambutol	$10.8K	1
Pyrazinamide 400MG tablet raw material	$3.0K	1

Undp Office IN Turkmenistan imports 14 distinct pharmaceutical formulations. Showing top 14 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Sofosbuvir	Antiviral & HIV Medications	$500.0K	10	1.2%	8
2	Velpatasvir	Antiviral & HIV Medications	$300.0K	6	1.2%	7

Undp Office IN Turkmenistan imports 2 pharmaceutical products across 1 categories into Turkmenistan totaling $800.0K.

Undp Office IN Turkmenistan — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

The United Nations Development Programme (UNDP) Office in Turkmenistan is a governmental entity operating under the auspices of the United Nations. Its primary mission is to support the Government of Turkmenistan in achieving sustainable development goals, with a significant focus on enhancing the nation's healthcare infrastructure. The office is headquartered in Ashgabat, the capital city of Turkmenistan. As a governmental procurement agency, the UNDP Office in Turkmenistan plays a pivotal role in sourcing and supplying essential medical products to the Ministry of Health and Medical Industry of Turkmenistan. This includes the procurement of pharmaceuticals, medical equipment, and other health-related commodities necessary for the effective delivery of healthcare services across the country.

2Distribution Network

While specific details regarding the UNDP Office in Turkmenistan's warehouse locations and logistics capabilities are not publicly disclosed, it is known that the office collaborates closely with the Ministry of Health and Medical Industry to ensure the efficient distribution of medical supplies. The UNDP's procurement processes are designed to facilitate timely and cost-effective delivery of health products, adhering to international standards and best practices. This collaboration ensures that medical products reach healthcare facilities throughout Turkmenistan, thereby supporting the nation's healthcare delivery system.

3Industry Role

In Turkmenistan's pharmaceutical supply chain, the UNDP Office functions as a central procurement agency. It is not a wholesaler, parallel importer, hospital supplier, or logistics intermediary. Instead, the UNDP Office is responsible for sourcing and supplying medical products directly to the Ministry of Health and Medical Industry, which then distributes these products to healthcare facilities across the country. This role is critical in ensuring the availability of essential medicines and medical supplies, particularly for the treatment of noncommunicable diseases (NCDs) and other health conditions prevalent in Turkmenistan.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Undp Office IN Turkmenistan

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

The UNDP Office in Turkmenistan's sourcing strategy exhibits a high degree of concentration, with a total import value of $800,000 USD from India across 16 shipments. The top five imported products—Sofosbuvir and Velpatasvir—account for 100% of the imports, indicating a focused procurement approach. This concentration suggests a strategic choice to streamline procurement processes and ensure the availability of specific, high-demand medications. However, such dependency on a limited number of suppliers and products could pose risks related to supply chain disruptions or changes in supplier conditions. The stability of these relationships is crucial, and any shifts in supplier reliability or geopolitical factors could impact the UNDP Office's ability to meet Turkmenistan's healthcare needs effectively.

2Supply Chain Resilience

The resilience of the UNDP Office in Turkmenistan's Indian supply chain is a critical factor in maintaining a steady supply of essential medications. The office's reliance on a limited number of suppliers—MYLAN LABORATORIES LIMITED, RR PHARMACEUTICALS PRIVATE LIMITED, LUPIN LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, and CADILA PHARMACEUTICALS LIMITED—suggests a focused sourcing strategy. However, this limited supplier base may expose the supply chain to risks such as production delays, quality issues, or geopolitical disruptions affecting trade routes. The UNDP Office's procurement processes are designed to mitigate such risks by adhering to international quality standards and maintaining transparent and fair procurement practices. Nonetheless, the office's ability to diversify its supplier base and establish contingency plans will be essential in enhancing the resilience of its supply chain.

Importing Pharmaceuticals into Turkmenistan — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Turkmenistan

1Regulatory Authority & Framework

The Ministry of Health and Medical Industry of Turkmenistan serves as the primary regulatory authority overseeing the importation and distribution of pharmaceutical products in the country. The regulatory framework governing pharmaceutical imports includes the Law of Turkmenistan No. 319-V "On Medical Supplies," which outlines the requirements for the state registration of medicinal products and medical devices. This law aims to ensure that imported medical products meet the established standards for safety, efficacy, and quality. The registration process involves compliance with national regulations and may require certification of conformity to prove adherence to international standards. Additionally, the UNDP Office's procurement processes are guided by principles of fairness, integrity, and transparency, ensuring that all procurement activities align with the mandates and principles of the United Nations.

2Import Licensing & GMP

Import licensing requirements in Turkmenistan are governed by the Ministry of Health and Medical Industry. For pharmaceutical products, obtaining an import license or permit is mandatory. This process involves applying for the necessary license through the relevant government agency and ensuring that all required documentation is in place before shipping the goods to avoid customs delays. Regarding Good Manufacturing Practice (GMP) certification, Turkmenistan recognizes international standards such as EU GMP, WHO GMP, and PIC/S. Pharmaceutical products imported into Turkmenistan must comply with these standards to ensure quality and safety. Additionally, wholesale distribution authorization is required for entities involved in the distribution of pharmaceutical products within the country.

Undp Office IN Turkmenistan — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

The UNDP Office in Turkmenistan's focus on antiviral and HIV medications, particularly Sofosbuvir and Velpatasvir, aligns with the country's healthcare priorities. These medications are essential for the treatment of hepatitis C, a significant public health concern in Turkmenistan. The decision to import these specific therapeutic areas is driven by the high demand for effective treatments and the UNDP's commitment to supporting the Ministry of Health and Medical Industry in addressing critical health issues. By ensuring the availability of these medications, the UNDP Office contributes to improving health outcomes and enhancing the quality of healthcare services in Turkmenistan.

2Sourcing Profile

The UNDP Office in Turkmenistan's sourcing strategy is centered on procuring generic drugs from reputable Indian manufacturers. This approach leverages India's robust pharmaceutical industry, known for producing high-quality generic medications at competitive prices. The focus on specific formulations, such as Sofosbuvir and Velpatasvir, reflects a targeted procurement strategy aimed at addressing the most pressing health needs in Turkmenistan. India's role as a supplier is integral to the UNDP Office's overall procurement strategy, ensuring a reliable and cost-effective supply of essential medications.

3Market Positioning

Seller's Guide — How to Become a Supplier to Undp Office IN Turkmenistan

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to engage with the UNDP Office in Turkmenistan, particularly if they can offer high-quality generic medications that meet international standards. Gaps in the UNDP Office's current sourcing include a limited supplier base and a narrow product focus. Indian exporters can capitalize on these gaps by demonstrating their capacity to provide a diverse range of pharmaceutical products, ensuring compliance with Turkmenistan's regulatory requirements, and establishing reliable supply chains. Building a strong relationship with the UNDP Office could lead to long-term partnerships and a stable market presence in Turkmenistan.

2Requirements & Qualifications

Indian exporters seeking to supply the UNDP Office in Turkmenistan must obtain the necessary import licenses or permits from the Ministry of Health and Medical Industry. Compliance with international GMP standards, such as EU GMP, WHO GMP, and PIC/S, is mandatory. Additionally, products must meet Turkmenistan's quality and labeling requirements, including batch testing, stability, and serialization mandates. Ensuring that products are registered and authorized for sale in Turkmenistan is essential for successful market entry.

Frequently Asked Questions — Undp Office IN Turkmenistan

What products does Undp Office IN Turkmenistan import from India?

Undp Office IN Turkmenistan imports 2 pharmaceutical products across 1 categories. Top imports: Sofosbuvir ($500.0K), Velpatasvir ($300.0K).

Who supplies pharmaceuticals to Undp Office IN Turkmenistan from India?

Undp Office IN Turkmenistan sources from 5 verified Indian suppliers. The primary supplier is Mylan Laboratories Limited (53.8% of imports, $448.8K).

What is Undp Office IN Turkmenistan's total pharmaceutical import value?

Undp Office IN Turkmenistan's total pharmaceutical import value from India is $800.0K, based on 16 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Undp Office IN Turkmenistan focus on?

Undp Office IN Turkmenistan imports across 1 categories. The largest: Antiviral & HIV Medications (100.0%).

Get Full Undp Office IN Turkmenistan Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.